Epitopea Announces Approval of OVACT Clinical Trial Application for CryptiVax-1001 in Advanced High-Grade Serous Ovarian Cancer
· Financial Post
Appoints Leading Oncologist Professor Susana Banerjee of The Royal Marsden as Chief Investigator Read More
Visit h-doctor.club for more information.